how much bacteriostatic water aod9604 for AOD-9604 AOD 9604 5 mg +
Description
Pivotal trial result: AOD-9604's Phase 2b trial (536 subjects, 24 weeks) failed its primary endpoint
AOD-9604 and BPC-157 are both peptides investigated for tissue healing but work through different mechanisms
Neurological recovery from B12 deficiency typically takes months, though some patients report reduced symptoms within weeks of starting treatment
Disclaimer: This spotlight is provided for educational purposes to acknowledge scientific contributions to AOD-9604 research
